|
|
|
Volumn 17, Issue 5, 2005, Pages 383-
|
|
FDA approves mandatory risk management program for isotretinoin.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ISOTRETINOIN;
KERATOLYTIC AGENT;
TERATOGENIC AGENT;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CONGENITAL MALFORMATION;
DEPRESSION;
DRUG CONTRAINDICATION;
DRUG MONITORING;
DRUG SURVEILLANCE PROGRAM;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MANDATORY PROGRAM;
ORGANIZATION AND MANAGEMENT;
PATIENT SELECTION;
RISK MANAGEMENT;
STANDARD;
UNITED STATES;
ABNORMALITIES, DRUG-INDUCED;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
DEPRESSION;
DRUG MONITORING;
HUMANS;
ISOTRETINOIN;
KERATOLYTIC AGENTS;
MANDATORY PROGRAMS;
PATIENT SELECTION;
RISK MANAGEMENT;
TERATOGENS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 33644837900
PISSN: 10603441
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
